Header Image

Investor Relations

Home | Contact Us | Site Map

Print this page

Investor Relations

Investor Relations

Corporate Profile

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, email us.
at

Copyright Nasdaq. Minimum 15 minutes delayed.

News
May 8, 2018
BioCryst Reports First Quarter 2018 Financial Results

RESEARCH TRIANGLE PARK, N.C. , May 08, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today financial results for the first quarter ended March 31, 2018 . “We are off to a strong start in 2018 as we continue to make progress advancing all our HAE development

Read More
Events

Investor Relations

Thomas Staab, Senior Vice President,
Chief Financial Officer
919.859.7910
investorrelations@biocryst.com

Merger Proxy Statement

For more information click here.

Stockholder Services

Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
1-800-937-5449 (toll free in US and Canada)
1-718-921-8200 (callers outside the US and Canada)